pd 98059 has been researched along with Parodontosis in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ara, T | 1 |
| Honjo, K | 1 |
| Fujinami, Y | 1 |
| Hattori, T | 1 |
| Imamura, Y | 1 |
| Wang, PL | 1 |
1 other study available for pd 98059 and Parodontosis
| Article | Year |
|---|---|
Preventive effects of a kampo medicine, orento on inflammatory responses in lipopolysaccharide treated human gingival fibroblasts.
Topics: Acetyltransferases; Anti-Inflammatory Agents; Cell Proliferation; Cell Survival; Dinoprostone; Dose- | 2010 |